By Heide Brandes
Copyright © 2013, Parkway Publishing LLC, All Rights Reserved
In a lab at Oklahoma Medical Research Foundation, scientists are cloning antibodies.
Funded by the newly formed Accele Biopharma Business Accelerator, a startup company is learning to use vaccines to strip DNA from antibodies in order to feed that DNA into specific germs. Those germs then spit out copies of the antibodies.
Whereas in the past, antibodies had to be replicated in mice, this new technology shaves off a year (not to mention hundreds of thousands of dollars) of work in cloning antibodies.